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miR-199b-5p is up-regulated signiﬁcantly during the osteogenesis process in human bone marrow
stromal cells (BMSCs). Inhibiting miR-199b-5p notably reduces while over-expressing miR-199b-5p
promotes the BMSCs osteoblast differentiation, suggested by the alternations of osteogenic genes
expression, ALP activity and the ARS-stained mineral nodules. miR-199b-5p exerts its role in BMSC
osteogenesis most probably through the GSK-3b/b-catenin signaling pathway. In conclusion, the present
study revealed for the ﬁrst time that miR-199b-5p plays a positive role in osteoblast differentiation.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Efﬁcacious bone regeneration could revolutionize the manage-
ment of bone and musculoskeletal disorders. Bone is one of the few
organs that retains its potential for continued regeneration into
adult life and is the only tissue that undergoes continual remod-
eling throughout life [1,2], and bone remodeling is precisely coor-
dinated by the interplay of osteoblasts and osteoclasts. The loss of
equilibrium between osteoblastic and osteoclastic functions may
result in bone diseases, such as osteoporosis or osteopetrosis [3].
Osteoblasts in the bone derive from bone marrow stromal cells
(BMSCs). BMSCs are multipotent stem cells that can differentiate
into bone, cartilage and adipose cells as well as into many other cell
types. In vivo and in vitro evaluations have demonstrated differ-
entiation of BMSCs along these lineages under the inﬂuence of local
stimuli, in many pre-clinical models, and the osteogenic capacity of
BMSCs has also been studied [4,5]. The differentiation of uncom-
mitted BMSCs to osteoblasts is a fundamental process, which is
positively or negatively regulated by numerous activators and re-
pressors [6,7]. A better understanding of the mechanisms by which
BMSCs osteogenesis is regulated is essential for its further
application.
Several molecules possess a role in regulating the differentiationcs, Xiangya Hospital Central
Hunan, PR China.
r Inc. This is an open access articleof BMSCs [8e10]. The GSK-3b/b-catenin signaling pathway appears
to be of particular importance, since its activation was required in
the BMSCs differentiation into osteoblast cells [11]. In particular, b-
catenin stabilization and induction of its translocation into the
nucleus play an important role in promoting BMSC osteogenic
differentiation.
Recently, several studies have investigated that miRNAs might
also be involved in the BMSCs differentiation into osteoblast cells
[12,13], of which 5miRNAs (miR-199b-5p, miR-218, miR-148a, miR-
135b, and miR-221) are more than 2-fold change in exosomes
isolated from BMSCs culture when compared with the maximum
changes at 0.5e7 days with the values at 0 day. In more detail, the
expression level of miR-199b-5p in BSMC exosomes is 3.75 ± 0.81
folds increased at day 4 of osteogenic differentiation compared to
that of day 0, which is the most signiﬁcantly altered. Moreover,
GSK-3b has been regarded as a direct target of miR-199b-5p. Given
all these, we hypothesized that miR-199b-5p might exert its reg-
ulatory effect by modulating GSK-3b/b-catenin signaling in BMSCs.
To prove our hypothesis, we investigated the effect of miR-199b-
5p on BMSC differentiation and bone formation. The expression
level of miR-199b-5p during BMSCs osteogenesis was examined.
Next, the effects of knockdown and overexpression of miR-199b-5p
on osteoblast differentiation were determined, with regard to
alkaline phosphatase (ALP) expression and activity, and expression
of osteogenic marker gene, Runx2. Furthermore, the expression
levels of GSK-3b, b-catenin, ALP and Runx2 were determined by
using Western blot assay. Our results showed that miR-199b-5p
promoted BMSC osteogenic potential through the regulation ofunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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miR-199b-5p and its analogs as rather promising drugs against
bone and musculoskeletal disorders.2. Material and methods
2.1. Isolation and culture of human BMSCs
Human BMSCs were isolated and expanded using amodiﬁcation
of methods previously reported [14]. The study has been approved
by the Xiangya Hospital Central South University; written informed
consent was obtained from all subjects or their parents in the case
of children. This work received approval from the institution ethics
committee and conformed to the tenets of the Declaration of Hel-
sinki. Eleven subjects (F/M ¼ 6/5; Age ¼ 25 ± 7) are with no
metabolic disease, inherited diseases and other diseases whichmay
affect the current study. Bone marrow aspirates were obtained
during routine orthopedic surgical procedures. Marrow aspirates
(20 ml volumes) were harvested using a bone marrow biopsy
needle inserted through the cortical bone; aspirates were imme-
diately resuspended in a-MEM (Life technologies; Carlsbad, CA)
containing 10% fetal bovine serum (FBS), 100 U/ml penicillin and
100 mg/l streptomycin (Life technologies), and cultured in a hu-
midiﬁed 37 C/5% CO2 incubator. hBMSC were selected on the basis
of adhesion and proliferation on tissue culture plastic substrate. The
obtained BMSCs were cultured and expanded for further experi-
ments. The BMSCs prior to passage four were used in the following
experiments. To induce osteoblastic differentiation, BMSCs were
cultured in an osteogenic medium (a-MEM supplemented with 10%
FBS, 50 mg/ml L-ascorbic acid, 10 mM glycerophosphate and
100 nMdexamethasone) and antibiotics (Sigma; St. Louis, MO) for 7
days.2.2. Cells culture and transfection
BMSCs were incubated in DMEM (Gibico, Invitrogen) with 10%Fig. 1. The expression of miR-199b-5p was altered during osteogenesis (A) The expression
miR-199b-5p were up-regulated in a differentiation time-dependent manner, and reached
identiﬁed by ARS staining in treated cells on day 0 and day 7. Results showed that after 7 da
data were presented as mean ± SD of three independent experiments.fetal bovine serum (Gibico, Invitrogen) and 100 U/mL penicillin/
streptomycin (Invitrogen). BMSCs were maintained at 37 C and 5%
CO2. miR-199b-5p mimics, miR-199b-5p inhibitor, and relevant
controls were purchased from Invitrogen. BMSCs were inoculated
into 6-well plates at a density of 4.0  105 per well and were
transiently transfected using Lipofectamine RNAiMAX (Invitrogen)
when they reached 60% conﬂuence. Cells were collected at 0 and
7 d after transfection, and 3 independent repeats were performed
for all experiments.2.3. Quantitative real time PCR (qRT-PCR)
After treating with experimental test agents, total cellular RNA
was extracted using TRizol reagent (Invitrogen). cDNA was syn-
thesized from 1 mg total RNA using a reverse transcription kit
(Takara). qRT-PCR with SYBR Greenwas performed using a Bio-Rad
real time PCR system following the manufacturer’s protocol. Melt-
curve analysis was conducted to verify that only one product was
produced. The mRNA levels of speciﬁc genes were calculated rela-
tive to the GAPDH levels using the 2DDCt method.2.4. Western blotting
Total cellular protein was collected using RIPA Lysis Buffer ac-
cording to the manufacturer’s instruction (Beyotime, China). Ali-
quots of protein from each sample were used to assay the protein
levels of ALP, Runx2, GSK-3b and b-catenin with GAPDH as the in-
ternal control. Antibodies were purchased from Abcam or Santa
Cruz Biotechnology. Proteins were subjected to SDS-PAGE on a 12%
polyacrylamide gel and transferred onto a PVDF membrane (Mil-
lipore, MA). After blocking with 5% nonfat milk in TBS containing
0.05% Tween-20, the membrane was incubated overnight at 4 C
with the primary antibody. Subsequently, the appropriate second-
ary antibody (horseradish peroxidase-conjugated) was added, and
bound antibody was visualized via chemiluminescence using an
ECL kit (Amersham, Germany).of miR-199b-5p was determined during BMSCs osteogenesis. The expression levels of
the highest level on day 7 compared to day 0. (B) The formed mineral nodules were
ys induction, the proportion of mineralization was increased compared with day 0. The
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On day 7, treated cells were washed twice with PBS and lysed by
two cycles of freezing and thaw. ALP activity in the cells was
measured colorimetrically by monitoring the release of p-nitro-
phenol from p-nitrophenyl phosphate at 37 C using an ALP assay
kit (Nanjing Jiancheng Biotech., China). Production of 1 mg p-
nitrophenol at 37 C in 15 min was described as 1 unit (U). ALP
activity was normalized to total protein, which was determined
using a BCA assay kit (Beyotime, China), and expressed as U/g
protein.
Following a 7-d treatment with the speciﬁed agents, ARS
staining was performed to detect the mineralized nodules in
BMSCs, as previously described [15]. Additionally, the bound dye
was dissolved with 10% cetylpyridinium chloride, and ARS in
samples was quantiﬁed by measuring absorbance at 550 nm. Par-
allel wells in culture were used for DNA isolation using a standard
kit (Beyotime, China). The stained ARS was normalized to total DNA
content, and expressed as mmol ARS/mg total DNA.2.6. Statistical analysis
Three independent repeats were performed for all experiments.Fig. 2. miR-199b-5p modulates osteogenic differentiation in BMSC (A) miR-199b-5p ove
hibition by miR-199b-5p inhibitor transfection. (B and C) The expression levels of ALP and
regulated after miR-199b-5p inhibition, compared to control and miR-NC group. (D) ALP a
reduced by miR-199b-5p inhibition in the mean time, compared to control and miR-NC groData were expressed as MEAN ± SD. Origin software was used to
analyze differences between samples, either by the two-sample
student t-test or by one-way ANOVA for differences between
selected pairs of samples. P < 0.05 was considered signiﬁcant.3. Results
3.1. The expression of miR-199b-5p was altered during osteogenesis
Firstly, we tested whether the expression of miR-199b-5p
changes during BMSCs osteogenesis. Osteoblast identiﬁcation was
achieved by using ARS staining assay, and the results were shown
in Fig. S1. BMSCs were cultured to induce osteoblastic differentia-
tion for 7 d, and the expression levels of miR-199b-5p and the
degrees of differentiation were determined on day 0, day 3 and day
7. Results showed that the expression levels of miR-199b-5p were
up-regulated in a differentiation time-dependent manner, and
reached the highest level on day 7 compared to day 0 (Fig. 1A). The
formed mineral nodules were identiﬁed by ARS staining in treated
cells on day 0 and day 7. Results showed that after 7 days induction,
the proportion of mineralization was increased compared with day
0 (Fig. 1B). These data indicated that miR-199b-5p expression
increased with the degree of BMSCs differentiation.rexpression was achieved by miR-199b-5p mimics transfection, and miR-199b-5p in-
Runx2 were up-regulated in response to miR-199b-5p overexpression while down-
ctivity in the cells was signiﬁcantly promoted by miR-199b-5p overexpression while
up. The data were presented as mean ± SD of three independent experiments.
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To further investigate the effect of miR-199b-5p on BMSCs dif-
ferentiation, we determined the expression and activity of ALP, and
the expression of Runx2 during BMSCs osteogenesis. miR-199b-5p
overexpression was achieved by miR-199b-5p mimics transfection,
and miR-199b-5p inhibition by miR-199b-5p inhibitor transfection
(Fig. 2A). Results showed that the expression levels of ALP and
Runx2 were up-regulated in response to miR-199b-5p over-
expression while down-regulated after miR-199b-5p inhibition,
compared to control and miR-NC group (Fig. 2B and C), in addition,
ALP activity in the cells was signiﬁcantly promoted bymiR-199b-5p
overexpression while reduced by miR-199b-5p inhibition in the
mean time, compared to control and miR-NC group (Fig. 2D). These
data suggested that miR-199b-5p plays an important role in stim-
ulating BMSCs osteoblast differentiation.3.3. GSK-3b/b-catenin signaling pathway was involved in
osteogenesis
Since GSK-3b has been regarded as a direct target of miR-199b-
5p, we further detected whether the GSK-3b/b-catenin signaling
pathway was associated with osteogenesis. We determined the
mRNA and protein expression of GSK-3b and b-catenin on day
0 and day 7 of the BMSCs differentiation. Results showed that GSK-
3b mRNA expression was down-regulated on day 7 compared to
day 0 (Fig. 3A), while b-catenin mRNA expressionwas up-regulated
on day 7 compared to day 0 (Fig. 3B). Consistent results were
observed with the protein expression of GSK-3b and b-catenin
(Fig. 3C), GSK-3b protein expression was down-regulated on day 7
compared to day 0, while b-catenin protein expression was up-
regulated on day 7 compared to day 0. These data suggested that
GSK-3b/b-catenin signaling pathway was involved in osteogenesis.Fig. 3. GSK-3b/b-catenin signaling pathway was involved in osteogenesis (A) GSK-3b mR
expression was up-regulated on day 7 compared to day 0. (C) GSK-3b protein expression wa
up-regulated on day 7 compared to day 0. The data were presented as mean ± SD of three3.4. miR-199b-5p regulates the BMSCs osteoblast differentiation
through GSK-3b/b-catenin signaling pathway by directly targeting
GSK-3b during osteogenesis
To further elucidate whether miR-199b-5p regulates the BMSCs
osteoblast differentiation through GSK-3b/b-catenin signaling
pathway during osteogenesis, we determined the protein expres-
sion of GSK-3b, b-catenin, ALP and Runx2 in response to miR-199b-
5p overexpression and inhibition by using Western blot assay. Re-
sults showed that GSK-3b protein expression was negatively
regulated by miR-199b-5p, in other words, up-regulated by miR-
199b-5p inhibition while down-regulated by miR-199b-5p over-
expression; b-catenin protein expressionwas up-regulated by miR-
199b-5p overexpression while down-regulated by miR-199b-5p
inhibition; compared to control and miR-NC group (Fig. 4A). In
addition, the protein expressions of ALP and Runx2 were both up-
regulated by miR-199b-5p overexpression while down-regulated
by miR-199b-5p inhibition, compared to control and miR-NC
group (Fig. 4B). In order to investigate the association of miR-
199b-5p with GSK-3b, we created a wild type GSK-3b 30 UTR
luciferase reporter vector (wt-GSK-3b), as well as two mutant GSK-
3b 30 UTR luciferase reporter vectors (mut-GSK-3b) by sequentially
mutating two predictedmiR-199b-5p binding sites in the GSK-3b 30
UTR (Fig. 4C). The wt-GSK-3b/mut-GSK-3b vectors and miR-NC/
miR-199b-5p mimics were co-transfected into cells. The luciferase
activity of the wt-GSK-3b vector was signiﬁcantly reduced by miR-
199b-5p mimics transfection, compared to control groups (Fig. 4C).
Moreover, miR-199b-5p-mediated repression of GSK-3b 30UTR
luciferase reporter activity was abolished by mutation of the pu-
tative miR-199b-5p binding sites in the GSK-3b 30UTR (Fig. 4C).
These data suggested that miR-199b-5p regulates the BMSCs
osteoblast differentiation through GSK-3b/b-catenin signaling
pathway by directly targeting to GSK-3b 30UTR during osteogenesis.NA expression was down-regulated on day 7 compared to day 0. (B) b-catenin mRNA
s down-regulated on day 7 compared to day 0, while b-catenin protein expression was
independent experiments.
Fig. 4. miR-199b-5p regulates the BMSCs osteoblast differentiation through GSK-3b/b-catenin signaling pathway during osteogenesis (A) GSK-3b protein expression was up-
regulated by miR-199b-5p inhibition while down-regulated by miR-199b-5p overexpression; b-catenin protein expression was up-regulated by miR-199b-5p overexpression while
down-regulated by miR-199b-5p inhibition; compared to control and miR-NC group. (B) The protein expressions of ALP and Runx2 were both up-regulated by miR-199b-5p
overexpression while down-regulated by miR-199b-5p inhibition, compared to control and miR-NC group. (C) The wt-GSK-3b/mut-GSK-3b vectors and NC mimics/miR-199b-5p
mimics were co-transfected into cells. The luciferase activity of the GSK-3b 30UTR luciferase reporter vector was signiﬁcantly reduced in miR-199b-5p mimics transfected cells,
compared to control groups. miR-199b-5p-mediated repression of GSK-3b reporter activity was abolished by the mutation of the putative miR-199b-5p binding sites in the GSK-3b
30UTR. The data were presented as mean ± SD of three independent experiments.
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The physiological role of microRNAs (miRNAs) in osteoblast
differentiation remains elusive. Recently, emerged evidences have
revealed that miRNAs are correlated with osteogenesis. Baglio et al.demonstrated that primary MSCs release small RNAs via exosomes,
which are increasingly implicated in intercellular communications
[16]. Bioinformatic analysis by DIANA-mirPath demonstrated that
several miRNAs expression altered during osteogenic differentia-
tion, suggesting exosomal miRNA is a regulator of osteoblast
R. Zhao et al. / Biochemical and Biophysical Research Communications 477 (2016) 749e754754differentiation [12]. The present study elucidates the expression of
miR-199b-5p, and the function of miR-199b-5p during osteoblast
differentiation in human BMSCs.
In the course of BMSC osteogenesis, miR-199b-5p was signiﬁ-
cantly up-regulated on day 7, compared to that of day 0. At the
meantime, we also found a higher proportion of mineralization on
day 7 than that of day 0. The expression alternation of miR-199b-5p
indicated that it might be involved in osteoblast differentiation.
This was consistent with the previous study, which indicated that
miR-199b expression was up-regulated in BMSC [12].
miR-199b-5p functions as a positive regulator of osteogenesis,
since knockdown of miR-199b-5p inhibited, whereas over-
expression of it enhanced, the expression levels of ALP and Runx2
and the ALP activity, which indicating the osteoblast differentiation
degree of BMSCs. The ﬁndings were supported by the mRNA
changes of Runx2 and ALP, and the activation of ALP activity.
However, the mechanism by which miR-199b-5p activates the
osteoblast differentiation of BMSCs still remained unclear. Runx2 is
a critical transcription factor in osteogenesis. Previous study has
establish GSK-3b as a key attenuator of Runx2 activity in bone
formation [17]. Given this, we next detected the association be-
tween osteogenesis and GSK-3b. Results showed that GSK-3b
expressionwas down-regulated onmRNA and protein levels on day
7 compared to day 0, while b-catenin mRNA expression was up-
regulated on mRNA and protein levels on day 7 compared to day
0, indicating that GSK-3b/b-catenin signaling pathway was
involved in osteogenesis.
To further investigate the association between GSK-3b and miR-
199b-5p, we further detected whether miR-199b-5p regulates the
BMSCs osteoblast differentiation through GSK-3b/b-catenin
signaling pathway during osteogenesis. GSK-3b protein expression
was up-regulated by miR-199b-5p inhibition while down-
regulated by miR-199b-5p overexpression; b-catenin protein
expressionwas up-regulated bymiR-199b-5p overexpressionwhile
down-regulated bymiR-199b-5p inhibition. In addition, the protein
expressions of ALP and Runx2 were both up-regulated by miR-
199b-5p overexpression while down-regulated by miR-199b-5p
inhibition. These data suggested that miR-199b-5p regulates the
BMSCs osteoblast differentiation through GSK-3b/b-catenin
signaling pathway during osteogenesis.
In summary, miR-199b-5p is induced during osteoblast differ-
entiation of BMSCs. miR-199b-5p acts as an activator in osteoblast
differentiation, because knockdown of miR-199b-5p reduces, while
overexpression of it enhances, the differentiation process. miR-
199b-5p associates with ALP and Runx2 expression, as well as
ALP activity. Moreover, miR-199b-5p regulates the BMSCs osteo-
blast differentiation through GSK-3b/b-catenin signaling pathway
during osteogenesis. Collectively, miR-199b-5p functions as a pos-
itive regulator in osteoblast differentiation of BMSCs.Funding sources
This work was supported by the National Natural Science
Foundation of China (Nos. 81402224, 81501890), the Science and
Technology Bureau of Hunan Province (2012FJ6001), the Science
and Technology Ofﬁce of Changsha City (K1203040-31), the Health
and Family Planning Commission of Hunan Province (B2014-12).Conﬂicts of interest
The authors declare that there is no conﬂict of interest regarding
the publication of this paper.Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.bbrc.2016.06.130.References
[1] J. Luo, M.H. Sun, Q. Kang, Y. Peng, W. Jiang, H.H. Luu, Q. Luo, J.Y. Park, Y. Li,
R.C. Haydon, T.C. He, Gene therapy for bone regeneration, Curr. Gene Ther. 5
(2005) 167e179.
[2] L. Chen, W. Jiang, J. Huang, B.C. He, G.W. Zuo, W. Zhang, Q. Luo, Q. Shi,
B.Q. Zhang, E.R. Wagner, J. Luo, M. Tang, C. Wietholt, X. Luo, Y. Bi, Y. Su, B. Liu,
S.H. Kim, C.J. He, Y. Hu, J. Shen, F. Rastegar, E. Huang, Y. Gao, J.L. Gao, J.Z. Zhou,
R.R. Reid, H.H. Luu, R.C. Haydon, T.C. He, Z.L. Deng, Insulin-like growth factor 2
(IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone for-
mation, J. Bone Min. Res. 25 (2010) 2447e2459.
[3] L.L. Zhu, S. Zaidi, Y. Peng, H. Zhou, B.S. Moonga, A. Blesius, I. Dupin-Roger,
M. Zaidi, L. Sun, Induction of a program gene expression during osteoblast
differentiation with strontium ranelate, Biochem. Biophys. Res. Commun. 355
(2007) 307e311.
[4] S.P. Bruder, K.H. Kraus, V.M. Goldberg, S. Kadiyala, The effect of implants
loaded with autologous mesenchymal stem cells on the healing of canine
segmental bone defects, J. Bone Jt. Surg. Am. 80 (1998) 985e996.
[5] S.P. Bruder, A.A. Kurth, M. Shea, W.C. Hayes, N. Jaiswal, S. Kadiyala, Bone
regeneration by implantation of puriﬁed, culture-expanded human mesen-
chymal stem cells, J. Orthop. Res. 16 (1998) 155e162.
[6] T. Imai, H. Ii, K. Yaegaki, T. Murata, T. Sato, T. Kamoda, Oral malodorous
compound inhibits osteoblast proliferation, J. Periodontol. 80 (2009)
2028e2034.
[7] J.C. Gallagher, A.J. Sai, Molecular biology of bone remodeling: implications for
new therapeutic targets for osteoporosis, Maturitas 65 (2010) 301e307.
[8] I. D’Alimonte, A. Lannutti, C. Pipino, P. Di Tomo, L. Pierdomenico, E. Cianci,
I. Antonucci, M. Marchisio, M. Romano, L. Stuppia, F. Caciagli, A. Pandolﬁ,
R. Ciccarelli, Wnt signaling behaves as a “master regulator” in the osteogenic
and adipogenic commitment of human amniotic ﬂuid mesenchymal stem
cells, Stem Cell Rev. 9 (2013) 642e654.
[9] C. Shui, T.C. Spelsberg, B.L. Riggs, S. Khosla, Changes in Runx2/Cbfa1 expres-
sion and activity during osteoblastic differentiation of human bone marrow
stromal cells, J. Bone Min. Res. 18 (2003) 213e221.
[10] Y.Q. Yang, Y.Y. Tan, R. Wong, A. Wenden, L.K. Zhang, A.B. Rabie, The role of
vascular endothelial growth factor in ossiﬁcation, Int. J. Oral Sci. 4 (2012)
64e68.
[11] Y.Y. Lin, C.Y. Chen, T.Y. Chuang, Y. Lin, H.Y. Liu, H.J. Mersmann, S.C. Wu,
S.T. Ding, Adiponectin receptor 1 regulates bone formation and osteoblast
differentiation by GSK-3beta/beta-catenin signaling in mice, Bone 64 (2014)
147e154.
[12] J.F. Xu, G.H. Yang, X.H. Pan, S.J. Zhang, C. Zhao, B.S. Qiu, H.F. Gu, J.F. Hong,
L. Cao, Y. Chen, B. Xia, Q. Bi, Y.P. Wang, Altered microRNA expression proﬁle in
exosomes during osteogenic differentiation of human bone marrow-derived
mesenchymal stem cells, PLoS One 9 (2014) e114627.
[13] B. Bakhshandeh, M. Soleimani, M. Haﬁzi, S.H. Paylakhi, N. Ghaemi, MicroRNA
signature associated with osteogenic lineage commitment, Mol. Biol. Rep. 39
(2012) 7569e7581.
[14] J.R. Mauney, C. Jaquiery, V. Volloch, M. Heberer, I. Martin, D.L. Kaplan, In vitro
and in vivo evaluation of differentially demineralized cancellous bone scaf-
folds combined with human bone marrow stromal cells for tissue engineer-
ing, Biomaterials 26 (2005) 3173e3185.
[15] C.M. Stanford, P.A. Jacobson, E.D. Eanes, L.A. Lembke, R.J. Midura, Rapidly
forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP), J. Biol.
Chem. 270 (1995) 9420e9428.
[16] S.R. Baglio, K. Rooijers, D. Koppers-Lalic, F.J. Verweij, M. Perez Lanzon, N. Zini,
B. Naaijkens, F. Perut, H.W. Niessen, N. Baldini, D.M. Pegtel, Human bone
marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in
distinctive miRNA and tRNA species, Stem Cell Res. Ther. 6 (2015) 127.
[17] F. Kugimiya, H. Kawaguchi, S. Ohba, N. Kawamura, M. Hirata, H. Chikuda,
Y. Azuma, J.R. Woodgett, K. Nakamura, U.I. Chung, GSK-3beta controls
osteogenesis through regulating Runx2 activity, PLoS One 2 (2007) e837.
